Created in 2008 (Belgium), AccessBioTherapeutics own 359 sister brands and 2214 competing brands. AccessBioTherapeutics is owned by UCB, listed on the stock exchange of Bruxelles The ISIN, the company's International Securities Identification Number, is BE0003739530. AccessBioTherapeutics is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
UCB
(AccessBioTherapeutics)
over 5 years*
EUR 203.59